UnknownPhase 3

Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally

Egypt200 participantsStarted 2014-11

Plain-language summary

200 women with PPH will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Ergometrine 400µgm (Methergin® Novartis, Switzerland) and group 2 will receive oxytocin 10 IU (Syntocinon®, Novartis, Switzerland). The investigators will not include a control group for ethical reasons.

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Atonic PPH Exclusion Criteria: * Gestational age\<37 weeks * Hypertension, cardiac disease or preeclampsia

What they're measuring

Need for other uterotonics

Timeframe: 2 minutes after giving the drug

Trial details

NCT IDNCT02306733

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-10

Contact for this trial

AbdelGany MA Hassan, MRCOG, MD

00201017801604 abdelgany2@gmail.com

View on ClinicalTrials.gov More Post Partum Hemorrhage trials